MAX-10181 Given Orally to Patients With Advanced Solid Tumor
NCT04122339
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
30
Enrollment
INDUSTRY
Sponsor class
Conditions
Solid Tumor
Interventions
DRUG:
MAX-10181
Sponsor
Maxinovel Pty., Ltd.